Cancer and immunity: who is shaping whom?

Himanshu Kumar
DOI: https://doi.org/10.1080/08830185.2021.1946300
2021-07-20
International Reviews of Immunology
Abstract:A disease caused by uncontrolled cell division, known as cancer, is a complex multifactorial state involving multiple intrinsic and extrinsic factors in development. The host immune system plays a crucial role in the surveillance of cancer or tumor cells. Various cells in the immune system continuously scan for these modified cells and eliminate them. The host immune system broadly consists of two major systems, the innate and the adaptive immune system. Type I interferons and natural killer (NK) cells are components of the innate immune system that control cancerous cells through their antiproliferative and proapoptotic properties and through direct killing, respectively. Adaptive immune components such as subset of CD4+ (helper) and CD8+ (cytotoxic) T cells and type II interferons restrict the growth of cancerous cells. On another hand, the cancerous tissue and its microenvironment skews normal regulatory T (Treg) cells to become cancer-derived Treg cells, which has conspicuous suppressive effects on antitumor cytotoxic T cells. Furthermore, the suppressive effects are enhanced or maintained by the induction of various cytokines such as IL-10 and TGF-beta. All these responses make cancerous cells resistant to apoptosis and promote anticancer immune evasion and establish cancer development. This issue of International Reviews of Immunology focuses on extrinsic and intrinsic oncogenic and anticancer factors (Figure 1).
immunology
What problem does this paper attempt to address?